BACE1 and Alzheimer disease: The levels of miR-29a/b-1 and miR-29c were decreased in the brains of patients with sporadic AD in other studies, and levels of both the BACE1 mRNA and protein were increased by targeting BACE1 expression through these miRNAs (Hebert et al., 2008; Lei et al., 2015).